CCL5 and neoplasm: Indeed, in the mouse PDX (patient-derived xenografts) model of human malignant phyllodes tumor, intraperitoneal injection of maraviroc, CCR5 inhibitor, or CCL5 neutralizing antibody prevents the recruitment of monocytes to tumors and dramatically suppress tumor growth (21).